CARsgen Therapeutics Holdings Limited
Status: Publicly traded
Direct answer
CARsgen Therapeutics Holdings Limited is publicly traded on HKSE under the ticker 2171.HK.
CARsgen Therapeutics Holdings Limited, a biopharmaceutical firm founded in Shanghai, China, in 2014, focuses on the discovery, development, and commercialization of advanced chimeric antigen receptor T (CAR-T) cell therapies. The company's efforts are directed toward treating various hematological malignancies and solid tumors across China and the United States. Its robust pipeline includes several key candidates:...
Can you invest in CARsgen Therapeutics Holdings Limited?
Yes. CARsgen Therapeutics Holdings Limited is publicly traded on HKSE under the ticker 2171.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CARsgen Therapeutics Holdings Limited
Detailed equity research is provided by MarketSnap.